Literature DB >> 31409174

Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood-brain barrier transporters.

Yutaro Hoshi1, Yasuo Uchida1, Takashi Kuroda1, Masanori Tachikawa1, Pierre-Olivier Couraud2, Takashi Suzuki3, Tetsuya Terasaki1.   

Abstract

The purpose of this study was to clarify the roles of ERM proteins (ezrin/radixin/moesin) in the regulation of membrane localization and transport activity of transporters at the human blood-brain barrier (BBB). Ezrin or moesin knockdown in a human in vitro BBB model cell line (hCMEC/D3) reduced both BCRP and GLUT1 protein expression levels on the plasma membrane. Radixin knockdown reduced not only BCRP and GLUT1, but also P-gp membrane expression. These results indicate that P-gp, BCRP and GLUT1 proteins are maintained on the plasma membrane via different ERM proteins. Furthermore, moesin knockdown caused the largest decrease of P-gp and BCRP efflux activity among the ERM proteins, whereas GLUT1 influx activity was similarly reduced by knockdown of each ERM protein. To investigate how moesin knockdown reduced P-gp efflux activity without loss of P-gp from the plasma membrane, we examined the role of PKCβI. PKCβI increased P-gp phosphorylation and reduced P-gp efflux activity. Radixin and moesin proteins were detected in isolated human brain capillaries, and their protein abundances were within a 3-fold range, compared with those in hCMEC/D3 cell line. These findings may mean that ezrin, radixin and moesin maintain the functions of different transporters in different ways at the human BBB.

Entities:  

Keywords:  Blood–brain barrier; ERM proteins; P-glycoprotein; breast cancer resistance protein; glucose transporter 1

Mesh:

Substances:

Year:  2019        PMID: 31409174      PMCID: PMC7308513          DOI: 10.1177/0271678X19868880

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

Review 1.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

2.  Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay.

Authors:  Brian T Hawkins; Robert R Rigor; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

3.  Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.

Authors:  Djanybek M Adyshev; Nurgul K Moldobaeva; Venkateswaran R Elangovan; Joe G N Garcia; Steven M Dudek
Journal:  Cell Signal       Date:  2011-08-12       Impact factor: 4.315

4.  Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.

Authors:  Takuro Kobori; Shuhei Fujiwara; Kei Miyagi; Shinichi Harada; Kazuo Nakamoto; Takayuki Nakagawa; Hideo Takahashi; Minoru Narita; Shogo Tokuyama
Journal:  Drug Metab Pharmacokinet       Date:  2014-07-22       Impact factor: 3.614

5.  Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.

Authors:  Robert R Rigor; Brian T Hawkins; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-03       Impact factor: 6.200

6.  Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells.

Authors:  Yasuo Uchida; Katsuaki Ito; Sumio Ohtsuki; Yoshiyuki Kubo; Takashi Suzuki; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2015-04-08       Impact factor: 5.372

7.  Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria.

Authors:  Junichi Kamiie; Sumio Ohtsuki; Ryo Iwase; Ken Ohmine; Yuki Katsukura; Kazunari Yanai; Yumi Sekine; Yasuo Uchida; Shingo Ito; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.

Authors:  Sumio Ohtsuki; Chiemi Ikeda; Yasuo Uchida; Yumi Sakamoto; Florence Miller; Fabienne Glacial; Xavier Decleves; Jean-Michel Scherrmann; Pierre-Olivier Couraud; Yoshiyuki Kubo; Masanori Tachikawa; Tetsuya Terasaki
Journal:  Mol Pharm       Date:  2012-12-11       Impact factor: 4.939

9.  Multichannel liquid chromatography-tandem mass spectrometry cocktail method for comprehensive substrate characterization of multidrug resistance-associated protein 4 transporter.

Authors:  Yasuo Uchida; Junichi Kamiie; Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-10-16       Impact factor: 4.200

10.  Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation.

Authors:  Mehran Haidari; Wei Zhang; James T Willerson; Richard Af Dixon
Journal:  Cardiovasc Diabetol       Date:  2014-07-15       Impact factor: 9.951

View more
  6 in total

1.  Neuronal Activity Regulates Blood-Brain Barrier Efflux Transport through Endothelial Circadian Genes.

Authors:  Robert S Pulido; Roeben N Munji; Tamara C Chan; Clare R Quirk; Geoffrey A Weiner; Benjamin D Weger; Meghan J Rossi; Sara Elmsaouri; Mario Malfavon; Aaron Deng; Caterina P Profaci; Marie Blanchette; Tongcheng Qian; Koji L Foreman; Eric V Shusta; Michael R Gorman; Frédéric Gachon; Stefan Leutgeb; Richard Daneman
Journal:  Neuron       Date:  2020-09-25       Impact factor: 17.173

2.  Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.

Authors:  Takuro Kobori; Mayuka Tameishi; Chihiro Tanaka; Yoko Urashima; Tokio Obata
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

3.  Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins.

Authors:  Tong Wu; Yun Sheng; Yuan-Yuan Qin; Wei-Min Kong; Meng-Meng Jin; Han-Yu Yang; Xiao-Ke Zheng; Chang Dai; Ming Liu; Xiao-Dong Liu; Li Liu
Journal:  Acta Pharmacol Sin       Date:  2021-02-08       Impact factor: 7.169

Review 4.  The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier.

Authors:  William M Pardridge
Journal:  Front Physiol       Date:  2020-05-07       Impact factor: 4.566

5.  iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment.

Authors:  Zhongxiang Zhang; Jiangtao Yu; Pengcheng Wang; Lian Lin; Ruining Liu; Rong Zeng; Haoli Ma; Yan Zhao
Journal:  Mol Brain       Date:  2021-01-27       Impact factor: 4.041

6.  Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration.

Authors:  Yan-Qi Li; Zhi Zheng; Quan-Xing Liu; Xiao Lu; Dong Zhou; Jiao Zhang; Hong Zheng; Ji-Gang Dai
Journal:  World J Surg Oncol       Date:  2021-04-10       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.